Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 6, 2021

Total Value ($000): $624,578 (100.0% shares, 0.0% debt)

Holdings (21)

BBIO BridgeBio Pharma Inc. (BBIO) 59.2%

Value ($000) $369,913 Shares 6,068,125 Est. Cost $40.43 Unrealized +41.3%

— Elevation Oncology Inc. (ELEV) 6.2%

Value ($000) $38,470 Shares 2,834,910 Est. Cost $13.57 Unrealized —

GLUE Monte Rosa Therapeutics Inc. (GLUE) 5.4%

Value ($000) $33,422 Shares 1,472,331 Est. Cost $20.37 Unrealized 0.0%

HRMY Harmony Biosciences Holdings Inc. (HRMY) 3.8%

Value ($000) $23,793 Shares 842,815 Est. Cost $36.46 Unrealized -17.7%

NUVB Nuvation Bio Inc. (NUVB) 3.8%

Value ($000) $23,657 Shares 2,541,009 Est. Cost $11.18 Unrealized +2.0%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 2.8%

Value ($000) $17,599 Shares 1,025,000 Est. Cost $10.24 Unrealized +78.9%

— Spruce Biosciences, Inc. (SPRB) 2.2%

Value ($000) $13,514 Shares 1,205,511 Est. Cost $24.31 Unrealized —

BMEA Biomea Fusion Inc. (BMEA) 2.0%

Value ($000) $12,469 Shares 798,757 Est. Cost $17.65 Unrealized 0.0%

— Aeglea Biotherapeutics Inc. (AGLE) 1.9%

Value ($000) $11,770 Shares 1,691,151 Est. Cost $8.00 Unrealized —

ACRS Aclaris Theraputics Inc. (ACRS) 1.8%

Value ($000) $11,141 Shares 634,455 Est. Cost $10.31 Unrealized +120.4%

— Poseida Therapeutics Inc. (PSTX) 1.7%

Value ($000) $10,454 Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Talaris Therapeutics Inc. (TALS) 1.6%

Value ($000) $10,032 Shares 682,923 Est. Cost $14.69 Unrealized —

— AVROBIO, Inc. (AVRO) 1.4%

Value ($000) $8,977 Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 1.4%

Value ($000) $8,769 Shares 3,142,857 Est. Cost $4.35 Unrealized —

— Verona Pharma plc (VRNA) 1.4%

Value ($000) $8,714 Shares 1,332,485 Est. Cost $7.38 Unrealized —

— Reneo Pharmaceuticals Inc. (RPHM) 1.3%

Value ($000) $8,267 Shares 886,075 Est. Cost $9.33 Unrealized —

— ObsEva SA (OBSV) 0.7%

Value ($000) $4,201 Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Atreca Inc. (BCEL) 0.5%

Value ($000) $3,303 Shares 387,653 Est. Cost $18.84 Unrealized —

— Viracta Therapeutics Inc. (VIRX) 0.5%

Value ($000) $3,272 Shares 288,571 Est. Cost $11.34 Unrealized —

— Zosano Pharma Corporation (ZSAN) 0.4%

Value ($000) $2,583 Shares 2,718,226 Est. Cost $2.15 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.0%

Value ($000) $258 Shares 191,028 Est. Cost $1.66 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$369,913	59.2%	$40.43	+41.3%	COM	10806X102
—	Elevation Oncology Inc. (ELEV)	2,834,910	$38,470	6.2%	$13.57	—	COM	28623U101
GLUE	Monte Rosa Therapeutics Inc. (GLUE)	1,472,331	$33,422	5.4%	$20.37	0.0%	COM	61225M102
HRMY	Harmony Biosciences Holdings Inc. (HRMY)	842,815	$23,793	3.8%	$36.46	-17.7%	COM	413197104
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$23,657	3.8%	$11.18	+2.0%	COM CL A	67080N101
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$17,599	2.8%	$10.24	+78.9%	COM	87164F105
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$13,514	2.2%	$24.31	—	COM	85209E109
BMEA	Biomea Fusion Inc. (BMEA)	798,757	$12,469	2.0%	$17.65	0.0%	COM	09077A106
—	Aeglea Biotherapeutics Inc. (AGLE)	1,691,151	$11,770	1.9%	$8.00	—	COM	00773J103
ACRS	Aclaris Theraputics Inc. (ACRS)	634,455	$11,141	1.8%	$10.31	+120.4%	COM	00461U105
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$10,454	1.7%	$8.87	—	COM	73730P108
—	Talaris Therapeutics Inc. (TALS)	682,923	$10,032	1.6%	$14.69	—	COM	87410C104
—	AVROBIO, Inc. (AVRO)	1,009,779	$8,977	1.4%	$16.72	—	COM	05455M100
—	Marker Therapeutics, Inc. (MRKR)	3,142,857	$8,769	1.4%	$4.35	—	COM	57055L107
—	Verona Pharma plc (VRNA)	1,332,485	$8,714	1.4%	$7.38	—	SPONSORED ADS	925050106
—	Reneo Pharmaceuticals Inc. (RPHM)	886,075	$8,267	1.3%	$9.33	—	COM	75974E103
—	ObsEva SA (OBSV)	1,386,338	$4,201	0.7%	$12.66	—	COM	H5861P103
—	Atreca Inc. (BCEL)	387,653	$3,303	0.5%	$18.84	—	CL A COM	04965G109
—	Viracta Therapeutics Inc. (VIRX)	288,571	$3,272	0.5%	$11.34	—	COM	92765F108
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$2,583	0.4%	$2.15	—	COM NEW	98979H202
—	Nabriva Therapeutics plc (NBRV)	191,028	$258	0.0%	$1.66	—	SHS	G63637113